openPR Logo
Press release

Epilepsy Therapeutics Market grows with development of antiepileptic medicines with diverse mechanism actions

11-28-2016 11:30 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Epilepsy Therapeutics Market grows with development

Epilepsy is a group of long-term neurological disorders that is characterized by recurring seizures. These seizures are episodes that occur when group of nerve cells or neurons in brain sends wrong signals. Seizures could differ from primary generalized seizures to partial seizures depending upon the cause of the epilepsy. Patients suffering from epilepsy may complain about strange emotions and sensations or they may behave strangely. Epilepsy is the fourth most common brain disorder affecting people of all ages. For the treatment of epilepsy, doctors prescribe antiepileptic medicines (AEDs) and the preference for the drug depends on the type of seizures to be treated, age of the patient, part of the brain involved and seriousness of the seizures. On the basis of the available AEDs, epilepsy therapeutics market is segmented into two major categories namely first generation AEDs and second generation AEDs. First generation AEDs consist of following drugs:

Read Full Report: http://www.transparencymarketresearch.com/epilepsy-therapeutics-market.html

Carbamazepine (Carbatrol)
Valproate (Depakote)
Oxycarbazepine ((Trileptal)
Phenytoin (Dilantin, Phenytek)
Ethosuximide (Zarontin)
Phenobarbital (Luminal)
Primidone (Mysoline)
Topiramate (Topamax)

Second generation AEDs consist of medicines with different mechanism of action than the first generation drugs. This segment of epilepsy therapeutics market consists of following drugs:

Pregabalin (Lyrica)
Lamotrigine (Lamictal)
Levetiracetam (Keppra)
Zonisamide (Zonegran)
Lacosamide (Vimpat)
Eslicarbazepine acetate (Aptiom/Zebinix)
Perampanel (Fycompa)
Ezogabine/retigabine (Trobalt/Potiga)
Rufinamide (Banzel/Inovelon)

First generation AEDs majorly carbamazepine, valproate, phenytoin and oxycarbazepine dominates the epilepsy therapeutics market. However, second generation AEDs such as levetiracetam, zonisamide and lacosamide are slowly overtaking the epilepsy therapeutics market due to its improved efficacy and tolerability. Additionally, large number of research and development activities, are going on all over the world for the development of antiepileptic medicines with diverse mechanism actions. As for instance two major players of epilepsy therapeutics market namely UCB Pharma Ltd. and Marinus Pharmaceuticals, Inc. has developed brivaracetam and ganaxolone respectively, for treating epilepsy. Both of these drugs are currently under clinical trials and it is expected that these drugs will prove beneficial for epilepsy therapeutics market.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2448

North America leads the epilepsy therapeutics market followed by Europe majorly due to the extensive research and development activities and availability of second generation drugs. Three new AEDs have been approved in U.S. since 2012 including ezogabine/retigabine, perampanel and eslicarbazepine acetate and it expected that brivaracetam will be approved soon. Ezogabine/retigabine and perampanel among these have novel mechanism of action and thus it is capturing good amount of market share in U.S. Continuous increase in uptake of second generation AEDs is also driving the epilepsy therapeutics market in North America and Europe. Asia-Pacific is also increasing at faster pace for epilepsy therapeutics market. High prevalence of epilepsy in India and China, increased penetration due to better market access options in China and expected approval of drugs with novel mechanisms are some of the factors responsible for expanding the epilepsy therapeutics market in the Asia-Pacific region. Conversely, the prescribing pattern of drugs that give preference to first generation AEDs over second generation AEDs is restraining the epilepsy therapeutics market in this region.

Some of the major players in epilepsy therapeutics market include Abbott Laboratories, GlaxoSmithKline plc, Cephalon, Inc., Johnson & Johnson, Pfizer, Inc., Novartis AG, Sunovion Pharmaceuticals, Inc.., Valeant Pharmaceuticals International, Inc., Sanofi S.A. and Shire.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epilepsy Therapeutics Market grows with development of antiepileptic medicines with diverse mechanism actions here

News-ID: 387815 • Views:

More Releases from TMR - Research Reports

Visualization and 3D Rendering Software Market: On-Premise Deployment Presently …
The global market for visualization and 3D rendering features a largely consolidated vendor landscape, with the leading three vendors accounting for a nearly 80% of the overall revenue generated in the market in 2016, observes Transparency Market Research in a recent report. These three vendors, namely Autodesk Inc., Dassault Systems, and NVIDIA Corporation, have strengthened their positions in the market with the help of cost competitive pricing, continuous introduction of
Digital Door Lock Systems Market: Enhanced Security Requirements to Propel the D …
According to a new market report published by Transparency Market Research titled “Digital Door Lock Systems Market–Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,” the global digital door lock systems market was valued at US$ 1,059.5 Mn in 2017 and is expected to expand at a CAGR of 30.25% from 2018 to 2026, reaching US$ 14,877.6 Mn by the end of the forecast period. digital door lock systems market
Transportation Management System Market: Advance Technologies in All the Sectors …
A transportation management system (TMS) refers to a subset of supply chain management and is centered mostly on logistics and transportation. The augmented use of cloud computing technologies for managing supply chain activities is one of the significant and major trends that have been prevailing in the world market for transportation management systems. Cloud-based deployments, in general, need less configuration and customization. These two factors are triggering down the cost
Energy Recovery Ventilators Market: Rising Awareness of Importance of Indoor Air …
Characterized by the presence of a handful of dominant players, namely United Technologies Corp., LG Electronics, Daikin Industries Ltd., Fujitsu Ltd., and Munters Corp., the global energy recovery ventilators market features intense competition, reveals Transparency Market Research (TMR) in a new report. Going forward, the rising number of players seeking entry will further intensify competition in the market. Expansion of product portfolio which has been the focus of established companies to

All 5 Releases


More Releases for AEDs

Antiepileptic Drugs (AEDs) Market Will Generate Record Revenue by 2029
Antiepileptic drugs market is anticipated to grow at a significant CAGR during the forecast period. Antiepileptic drugs (AEDs) are commonly known as anticonvulsants or antiseizure drugs. These drugs are used in the treatment of epileptic seizures. Epilepsy is a central neurological disorder that causes brain activity to become abnormal and further causes seizures or periods of unusual behaviour, sensations and sometimes loss of awareness. Additionally, these drugs are also used
Antiepileptic Drugs (AEDs) Market Trends, Size, Competitive Analysis and Forecas …
The global antiepileptic drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Antiepileptic drugs (AEDs) are commonly known as anticonvulsants or antiseizure drugs. These drugs are used in the treatment of epileptic seizures. Epilepsy is a central neurological disorder that causes brain activity to become abnormal and further causes seizures or periods of unusual behaviour, sensations and sometimes loss of awareness. Additionally, these drugs
Global ICU Automated External Defibrillators (AEDs) Market Huge Growth Opportuni …
LP INFORMATION recently released a research report on the ICU Automated External Defibrillators (AEDs) market analysis, which studies the ICU Automated External Defibrillators (AEDs)'s industry coverage, current market competitive status, and market outlook and forecast by 2025. Global "ICU Automated External Defibrillators (AEDs) Market 2020-2025" Research Report categorizes the global ICU Automated External Defibrillators (AEDs) market by key players, product type, applications and regions,etc. The report
Current Market Scenario of ICU Automated External Defibrillators (AEDs) Market
Market Overview The ICU Automated External Defibrillators (AEDs)market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. Market segmentation ICU Automated External Defibrillators (AEDs)market is split by Type and Application. For
Automated External Defibrillators (AEDs) Market to Witness Robust Expansion by 2 …
Market Research Report Store offers a latest published report on Automated External Defibrillators (AEDs) Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Automated External Defibrillators (AEDs) market will register a 6.1% CAGR in terms of revenue, the global market size will reach US$ 873.1 million by 2024, from US$ 688.7
Automated External Defibrillators (AEDs) Market: Competitive Dynamics & Global O …
LP INFORMATION offers a latest published report on Automated External Defibrillators (AEDs) Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Automated External Defibrillators (AEDs) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million